Skip to main content
Erschienen in: Diseases of the Colon & Rectum 8/2007

01.08.2007

Clinical and Pathologic Evaluation of Patients with Recurrence of Colorectal Cancer Five or More Years After Curative Resection

verfasst von: Yong Beom Cho, M.D., Ho-Kyung Chun, M.D., Ph.D., Hae Ran Yun, M.D., Won Suk Lee, M.D., Seong Hyeon Yun, M.D., Ph.D., Woo Yong Lee, M.D., Ph.D.

Erschienen in: Diseases of the Colon & Rectum | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Purpose

This study was designed to evaluate the characteristics of recurrences that occur five or more years after curative resection for colorectal cancer.

Methods

This study included a total of 352 patients who were confirmed as having recurrence after curative resection for colorectal cancer during the period from January 1995 to December 2000. Of the 352 patients, 231 had early recurrence (less than 2 years after operation), 103 had intermediate recurrence (2–5 years after operation), and 18 had late recurrence (more than 5 years after operation). The clinicopathologic findings of the patients with late recurrence were compared with those of the other two recurrence groups, with special reference to the pattern of recurrence.

Results

The rate of late recurrence was 1.2 percent. In the late recurrence group, males outnumbered females by a ratio of 3.5:1 and the mean level of preoperative carcinoembryonic antigen was 4.5 ng/ml, whereas that of the early recurrence group was 30.5 ng/ml. All the lesions in the cases with late recurrence except one lesion were located in the left colon or rectum, the tumors were small-sized and polypoid, and well-differentiated adenocarcinomas were more frequently observed. Distant metastasis, especially lung metastasis, was most frequently observed.

Conclusions

Late recurrent colorectal cancer has some characteristics compared with early or intermediate recurrence. Although recurrence at more than five years postoperatively is not common, its possibility should be considered whenever performing follow-up, and surveillance for lung metastasis is recommended after more than five years of surgery.
Literatur
1.
Zurück zum Zitat Carlsson, U, Lasson, A, Ekelund, G 1987Recurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracyDis Colon Rectum30431434PubMedCrossRef Carlsson, U, Lasson, A, Ekelund, G 1987Recurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracyDis Colon Rectum30431434PubMedCrossRef
2.
Zurück zum Zitat Galandiuk, S, Wieand, HS, Moertel, CG, et al. 1992Patterns of recurrence after curative resection of carcinoma of the colon and rectumSurg Gynecol Obstet1742732PubMed Galandiuk, S, Wieand, HS, Moertel, CG,  et al. 1992Patterns of recurrence after curative resection of carcinoma of the colon and rectumSurg Gynecol Obstet1742732PubMed
3.
Zurück zum Zitat Stipa, S, Nicolanti, V, Botti, C, et al. 1991Local recurrence after curative resection for colorectal cancer: frequency, risk factors and treatmentJ Surg Oncol Suppl2155160PubMedCrossRef Stipa, S, Nicolanti, V, Botti, C,  et al. 1991Local recurrence after curative resection for colorectal cancer: frequency, risk factors and treatmentJ Surg Oncol Suppl2155160PubMedCrossRef
4.
Zurück zum Zitat Landis, SH, Murray, T, Bolden, S, Wingo, PA 1999Cancer statistics, 1999CA Cancer J Clin49831PubMedCrossRef Landis, SH, Murray, T, Bolden, S, Wingo, PA 1999Cancer statistics, 1999CA Cancer J Clin49831PubMedCrossRef
5.
Zurück zum Zitat Castells, A, Bessa, X, Daniels, M, et al. 1998Value of postoperative surveillance after radical surgery for colorectal cancer: results of a cohort studyDis Colon Rectum41714723PubMedCrossRef Castells, A, Bessa, X, Daniels, M,  et al. 1998Value of postoperative surveillance after radical surgery for colorectal cancer: results of a cohort studyDis Colon Rectum41714723PubMedCrossRef
6.
Zurück zum Zitat Bokey, EL, Ojerskog, B, Chapuis, PH, Dent, OF, Newland, RC, Sinclair, G 1999Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissectionBr J Surg8611641170PubMedCrossRef Bokey, EL, Ojerskog, B, Chapuis, PH, Dent, OF, Newland, RC, Sinclair, G 1999Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissectionBr J Surg8611641170PubMedCrossRef
7.
Zurück zum Zitat Umpleby, HC, Bristol, JB, Rainey, JB, Williamson, RC 1984Survival of 727 patients with single carcinomas of the large bowelDis Colon Rectum27803810PubMedCrossRef Umpleby, HC, Bristol, JB, Rainey, JB, Williamson, RC 1984Survival of 727 patients with single carcinomas of the large bowelDis Colon Rectum27803810PubMedCrossRef
8.
Zurück zum Zitat Sadahiro, S, Suzuki, T, Ishikawa, K, et al. 2003Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten yearsHepatogastroenterology5013621366PubMed Sadahiro, S, Suzuki, T, Ishikawa, K,  et al. 2003Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten yearsHepatogastroenterology5013621366PubMed
9.
Zurück zum Zitat Blake, KE, Dalbow, MH, Concannon, JP, et al. 1982Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowelDis Colon Rectum252432PubMedCrossRef Blake, KE, Dalbow, MH, Concannon, JP,  et al. 1982Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowelDis Colon Rectum252432PubMedCrossRef
10.
Zurück zum Zitat Chu, DZ, Erickson, CA, Russell, MP, et al. 1991Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrenceArch Surg126314316PubMed Chu, DZ, Erickson, CA, Russell, MP,  et al. 1991Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrenceArch Surg126314316PubMed
11.
Zurück zum Zitat Harrison, LE, Guillem, JG, Paty, P, Cohen, AM 1997Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patientsJ Am Coll Surg1855559PubMed Harrison, LE, Guillem, JG, Paty, P, Cohen, AM 1997Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patientsJ Am Coll Surg1855559PubMed
12.
Zurück zum Zitat Carriquiry, LA, Pineyro, A 1999Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?Dis Colon Rectum42921929PubMedCrossRef Carriquiry, LA, Pineyro, A 1999Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?Dis Colon Rectum42921929PubMedCrossRef
13.
Zurück zum Zitat Eisenberg, B, Decosse, JJ, Harford, F, Michalek, J 1982Carcinoma of the colon and rectum: the natural history reviewed in 1704 patientsCancer4911311134PubMedCrossRef Eisenberg, B, Decosse, JJ, Harford, F, Michalek, J 1982Carcinoma of the colon and rectum: the natural history reviewed in 1704 patientsCancer4911311134PubMedCrossRef
14.
Zurück zum Zitat Crucitti, F, Sofo, L, Doglietto, GB, et al. 1991Prognostic factors in colorectal cancer: current status and new trendsJ Surg Oncol Suppl27682PubMedCrossRef Crucitti, F, Sofo, L, Doglietto, GB,  et al. 1991Prognostic factors in colorectal cancer: current status and new trendsJ Surg Oncol Suppl27682PubMedCrossRef
15.
Zurück zum Zitat Obrand, DI, Gordon, PH 1997Incidence and patterns of recurrence following curative resection for colorectal carcinomaDis Colon Rectum401524PubMedCrossRef Obrand, DI, Gordon, PH 1997Incidence and patterns of recurrence following curative resection for colorectal carcinomaDis Colon Rectum401524PubMedCrossRef
16.
Zurück zum Zitat Fisher, B, Wolmark, N, Rockette, H, et al. 1988Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01J Natl Cancer Inst802129PubMedCrossRef Fisher, B, Wolmark, N, Rockette, H,  et al. 1988Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01J Natl Cancer Inst802129PubMedCrossRef
17.
Zurück zum Zitat Moertel, CG, Fleming, TR, Macdonald, JS, et al. 1990Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaN Engl J Med322352358PubMedCrossRef Moertel, CG, Fleming, TR, Macdonald, JS,  et al. 1990Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaN Engl J Med322352358PubMedCrossRef
18.
Zurück zum Zitat Wolmark, N, Rockette, H, Fisher, B, et al. 1993The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03J Clin Oncol1118791887PubMed Wolmark, N, Rockette, H, Fisher, B,  et al. 1993The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03J Clin Oncol1118791887PubMed
19.
Zurück zum Zitat Weiss, L, Grundmann, E, Torhorst, J, et al. 1986Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsiesJ Pathol150195203PubMedCrossRef Weiss, L, Grundmann, E, Torhorst, J,  et al. 1986Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsiesJ Pathol150195203PubMedCrossRef
20.
Zurück zum Zitat Bruinvels, DJ, Stiggelbout, AM, Kievit, J, van Houwelingen , HC, Habbema, JD, van de Velde, CJ 1994Follow-up of patients with colorectal cancer. A meta-analysisAnn Surg219174182PubMedCrossRef Bruinvels, DJ, Stiggelbout, AM, Kievit, J, van Houwelingen , HC, Habbema, JD, van de Velde, CJ 1994Follow-up of patients with colorectal cancer. A meta-analysisAnn Surg219174182PubMedCrossRef
21.
Zurück zum Zitat Ovaska, J, Jarvinen, H, Kujari, H, Perttila, I, Mecklin, JP 1990Follow-up of patients operated on for colorectal carcinomaAm J Surg159593596PubMed Ovaska, J, Jarvinen, H, Kujari, H, Perttila, I, Mecklin, JP 1990Follow-up of patients operated on for colorectal carcinomaAm J Surg159593596PubMed
22.
Zurück zum Zitat Eckardt, VF, Stamm, H, Kanzler, G, Bernhard, G 1994Improved survival after colorectal cancer in patients complying with a postoperative endoscopic surveillance programEndoscopy26523527PubMedCrossRef Eckardt, VF, Stamm, H, Kanzler, G, Bernhard, G 1994Improved survival after colorectal cancer in patients complying with a postoperative endoscopic surveillance programEndoscopy26523527PubMedCrossRef
Metadaten
Titel
Clinical and Pathologic Evaluation of Patients with Recurrence of Colorectal Cancer Five or More Years After Curative Resection
verfasst von
Yong Beom Cho, M.D.
Ho-Kyung Chun, M.D., Ph.D.
Hae Ran Yun, M.D.
Won Suk Lee, M.D.
Seong Hyeon Yun, M.D., Ph.D.
Woo Yong Lee, M.D., Ph.D.
Publikationsdatum
01.08.2007
Erschienen in
Diseases of the Colon & Rectum / Ausgabe 8/2007
Print ISSN: 0012-3706
Elektronische ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-007-0247-0

Weitere Artikel der Ausgabe 8/2007

Diseases of the Colon & Rectum 8/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.